Apolipoprotein B (apoB) is a major protein component of low density and very low density lipoproteins. Because of its large size and heterogeneity, molecular studies of apoB have been difficult, and its structure and regulation remain poorly understood. We now report the identification of human apoB cDNA clones by antibody screening of hepatoma libraries in the expression vector Xgtll. Both oligo(dT) primed and random primed libraries were constructed and screened with polyclonal antibodies to intact apoB, as well as with antibodies raised against a synthetic peptide based on the limited amlno acid sequence available for apoB. The identity of the clones was unambiguously established by comparisons of the cloned cDNA sequences with apoB amino acid sequences. The clones hybridize to an exceptionally large 20 kb mFWA that is present in liver and intestine but not other tissues examined, consistent with the distribution expected from protein biosynthetic studies. The properties of the mENA have implications for the biogenesis of the multiple apoB molecular weight forms secreted by liver and intestine.
INTRODUCTION
Lipids are transported through the circulation as lipoprotein complexes consisting of a hydrophobic core of cholesterol ester and triglyceride surrounded by phospholipids, free cholesterol and various apolipoproteins.
Several classes of lipoproteins have been distinguished on the basis of density. Among these are chylomicrons and very low density lipoproteins (VLDL), which are secreted by intestine and liver, respectively, low density lipoproteins (LDL), which are derived in the circulation by lipolysis of VLDL, and high density lipoproteins (HDL), which are derived from precursor particles secreted by liver (1, 2) . Apolipoprotein B (apoB) is the major protein component of chylomicrons, VLDL and LDL, and it serves at least two crucial functions in lipoprotein metabolism. First, it is essential in the assembly and secretion of both VLDL and chylomicrons, since individuals with a rare genetic defect in the production of apoB, termed abetalipoproteinemia, are unable to produce these lipoproteins (3) . Second, it serves as a recogni-tion marker for the removal of LDL from the circulation by receptor-mediated uptake into a variety of cells (4) . It differs from other apolipoproteins in that it is an integral component of lipoproteinsj while other apolipoproteins can exchange between lipoprotein particles and are soluble in the absence of detergents, apoB is extremely hydrophobic and remains tightly associated with lipoprotein particles. Also, whereas other apolipoproteins range in size from about 6 kDa-45 kDa, apoB is among the largest peptides known with molecular weight estimates ranging from 250-550 kDa (3, (5) (6) (7) (8) (9) . The hydrophobicity and size of apoB have made its study difficult, and only recently have we succeeded in obtaining limited amino acid sequence information (10) . Furthermore, the protein exhibits size heterogeneity, with at least two major forms being present in the circulation. In humans, the liver synthesizes and incorporates into VLDL a species which we estimate has a molecular weight of about 400 kDa, while intestine incorporates into chylomicrons a smaller 210 kDa species. These 400 and 210 kDa species have been referred to as B100 and B48, respectively, and are synonymous with the PI and PHI species in Elovson's nomenclature (3, 7, 8) . The B100 but not the B48 species contains the recognition marker for uptake by the LDL receptor which has been extensively studies by Brown, Goldstein, and collaborators (3) . The mechanisms leading to the production of the two species are unclear.
Although moat forms of abetalipoproteinemia are characterized by failure in the production of both apoBlOO and apoB48, others are characterized by continued expression of apoB48 but not apoBlOO, raising the possibility that the two species are encoded by separate genes (3) . Cn the other hand, peptide fingerprinting and iramunological studies are consistent with their being derived from a common gene (8, (11) (12) (13) (14) .
Because of the difficulties in studying apoB at the protein level, we have sought to clone sequences encoding apoB to study questions concerning its structure and biogenesis. Also, a variety of studies have strongly implicated LDL, the major cholesterol carrier in human plasma, in the development of atherosclerosis, and accumulating evidence suggests that genetic variations affecting the structure and regulation of apoB may contribute to hypercholesterolemia and to atherosclerosis (15) (16) (17) (18) (19) . The availability of probes for the apoB gene should allow this possibility to be examined by providing markers to trace the inheritance of the gena in family studies. Efforts to clone apoB have been hampered by inability to translate apoB mISiA either in vitro or by microinjection into frog oocytes. Therefore, we adopted the approach of antibody screening of cDNA expression libraries using the Xgtll vector developed by Young and Davis (20) (21) (22) . We previously reported the isolation of rat apoB cDNA clones by antibody screening of a liver cDNA library (23) . The clones were found to hybridize to a 20 kb mRNA present in liver. Unfortunately, since there is no amino acid sequence information for rat apoB, the identity of the clones could be established only by immunological characterization of the expressed fusion proteins.
We now report the identification and characterization of human apoB cDNA clones by antibody screening of hepatoma cDNA expression libraries.
In order to unambiguously establish the identity of the clones by sequence comparisons, we specifically isolated clones corresponding to the very limited known apoB amino acid sequence (10) by screening the libraries with antibody prepared against a synthetic peptide constructed on the basis of that apoB amino acid sequence. The cloned probes identify a 20 kb mRNA in both liver and intestine, although the liver produces an apoB peptide roughly twice the size of that produced in intestine.
MATERIALS AND METHODS

Materials
Radioisotopes and enzymes were from Amersham and Bethesda Research Laboratories, respectively. Human jejunum tissue was obtained from gastric bypass surgery and was immediately placed in cold saline. Within 45 min., a 2 cm piece was cut longitudinally, washed in cold saline with shaking and frozen on dry ice. Rhesus monkey tissues were generous gifts of the Oregon Primate Center and of Dr. William Conner, University of Oregon Medical School.
All tissues were stored under liquid nitrogen until use.
Cell cultures
The Hep G2 cell line (24, 25) was grown in flasks with Eagles mininum essential medium supplemented with 10% fetal calf serum. Rates of apoB synthesis were estimated by culturing cells in methionine-free Eagles medium containing S-methionine for periods of 0.5-2 hrs. Homogenates were prepared in 1 mM phenylmethylsulfonyl fluoride, 7 mM EDTA (pH7), 0.1% sarcosyl, 0.2% Triton X-100. Radioactivity incorporated into apoB was determined following immunoprecipitation and SDS polyacrylamide gel electrophoresis.
Antibodies
Rabbit antiserum to .intact apoB was raised in rabbits against highly purified human LDL. It was shown to be monospecific for apoB by immuneblotting with human plasma. Affinity purified antibody was prepared by passing antiserum over a column of immobilized LDL followed by elution with 0.1 H glycine, pH3.
We previously isolated two proteolytic fragments of human apoB resulting from digestion with S. aureus protease in the presence of SDS and determined their amino terminal amino acid sequences (10) . A peptide corresponding to a portion of the sequence of one of these (R2-5) was synthesized by the solid phase method (26) and purchased from Penninsula laboratories, California. The sequence of the synthetic peptide was
Leu-Asp-Phe-Leu-Asn-Ile-Pro-Leu-Arg-Ile-Pro-Pro-Met-Arg. Antiserum specific for this peptide was prepared by immunizing rabbits with 200 \ig keyhole limpet hemocyanin (Klfl) coupled to the synthetic peptide in three injections as described by Green, et al. (27) . The antipeptide serum generated in this way was able to specifically react with ug quantities of denatured apoB.
This antiserum had a titer of 1:5000 when assayed for binding to 0.5 yg apoB immobilized on nitrocellulose filters (28) .
RNA and DNA isolation and filter hybridization RNA was prepared from tiasues by homogenization in guanidine thiocyanate followed by centrifugation over a cesium chloride cushion (29) . Poly(A) containing RNA was enriched by oligo(dT) cellulose chromatography. Genomic DNA was purified from isolated nuclei by incubation in 10 mM EDTA, pH8, 0.2% SDS, 600 pg/ml proteinase K (Sigma) at 37°C for 24 hr followed by phenol extraction and ethanol precipitation (30) . For Northern analysis KNA was electrophoresed on 0.75% agarose gels in the presence of formaldehyde and hybridized to cDNA probes as previously described (32). Ligation was performed using about 50 ng cDNA per yg Xgtll DNA. The ligated DNA was packaged using an extract purchased from Amersham and amplified on E. coli Y1088 (20, 21) . Phage were plated on E. coli strain Y1090 at a density of 1.5 x 10 phage per 150 mm plate and isopropyl thiogalactoside (IPTG) induced plaques were transferred to nitrocellulose filters (Schleicher and Schuell) (20, 21, 23) . Filters were reacted for 90 min at room temperature with rabbit antibodies diluted 1:1000 followed by treatment with I-protein A and autoradiography as described (2 3). Positive phage were taken through two or more rounds of plaque purification.
Characterization of fusion proteins.
Lysogens were prepared by infection of E. coli Y1089 cells (20, 21) .
Cell lysates, prepared as previously described (23) and suspended in 8M urea were subjected to electrophoresis on 8% SDS polyacrylamide gels.
Western blots were prepared by electrophoretic transfer to nitrocellulose.
Filters were incubated with the appropriate antibody overnight at room 125 temperature, washed, and developed with I-protein A followed by autoradiography, as described (23) .
RESULTS
Cloning strategy
The cloning and identification of apoB sequences present a special problem because in vitro translation of apoB mRNA has been unsuccessful and because apoB is among the largest known peptides, with a molecular weight of about 400 kDa, which would correspond to a coding sequence of about 11 kb.
Moreover, our previous studies of rat apoB suggest that the entire mRNA is about 20 kb in size, more than twice the size of any previously, reported mRNA species. With the objective of utilizing oligonucleotide screening of libraries, we obtained partial amino acid sequences for two apoB peptides isolated after partial proteolysis of human apoB (10) . The locations of these sequences along the apoB polypeptide are unknown. However, the use of corresponding short mixed oligonucleotide probes as well as longer unique probes based on codon usage failed to identify apoB sequences in ours and other laboratories. The reasons for this may involve the relatively ambiguous nature of the nucleic acid sequences predicted from the apoB amino acid sequence and the likelihood that the mRNA region encoding the peptide sequence is distant from the poly(A) tail used for priming cDNA synthesis. Therefore, we adopted the following alternative stragegy: A synthetic peptide derived from the ami no terminal sequence of apoB peptide R2-5 was synthesized, coupled to keyhole limpet hemocyanin, and used to
Immunize rabbits. The antiserum generated in this way was able to specifically react with )Jg quantities of denatured apoB and also with the expected antibodies (20) . On the basis of the very large size of rat apoB mRNA, we did not expect to synthesize and package full-length apoB cDNA. Therefore, the cDNA synthesis was primed by random oliganucleotides (38) , which should yield sequences along the entire length of the mRNA, as well as the conventional method of oligo(dT) priming, which should enrich for sequences at the The region of the cDNA sequence corresponding to the amino terminal sequence of an apoB proteolytic fragment is underlined. The sequence of the proteolytic fragment is shown below for comparison, and the amino acids which differ from those derived from the cDNA sequence are indicated by underlining.
protein epitope for antibody. Of the 12 clones examined, the signals of two (RP2 and A18) were strongly competed by the presence of excess peptide ( Fig.   1 ) and these were selected for further characterization as discussed below.
Characterization of apoB cDNA and fusion proteins.
In addition to the two clones identified with antibody to the synthetic peptide (RP2 and A18), two clones identified with antibody to intact apoB (A7h and A6c) were selected for further characterization on the basis of intensity of signal obtained with antibody screening and insert size. Three of these, A7h, A6c and A18, containing cDNA inserts of about 600 bp, 3500 bp and 550 bp respectively, were selected from the oligo(dT) primed library, while RP2, with an insert size of about 300 bp, was selected from the random primed library.
Clone RP2 was subcloned into M13 phage and sequenced by the dideoxy chain termination method. It contains a single open reading frame, continuous with lacZ, and the predicted amino acid sequence includes the entire amino acid sequence we previously obtained for apoB peptide E2-5 as well as flanking sequences (Fig. 2) . Three differences were observed between the sequence deduced from the CDNA and the amino terminal sequence determined for apoB peptide R2-5 (Fig. 2) . A reexamination of the amino acid sequencing data indicated that these differences are compatible with errors in amino acid sequence determination, although they could also result from allellc variation. The sequence is proceeded by a glutamic acid residue, which is expected since the peptide was derived by partial proteolysis with S. aureus V8 protease (10) The clones identified with antibody to intact apoB, A6c and A7h, failed to crosshybridize with clones A18 or RP2, but they crosshybridized with each other and also hybridized to common restriction fragments of human genomic DNA (data not shown), indicating that they overlap. Their identity was further examined by immunological characterization of the resulting fusion proteins. Lysogens of each clone were made in Y1089 cells, and freeze-thaw lysates of heat induced lysogens were prepared. These, along with a nonrecombinant Xgtll lysate, were analysed by immunoblotting after sodium dodecyl sulfate gel electrophoresis (Fig. 3 ). When probed with antigalactosidase, the nonrecombinant Xgtll gave the expected 116 kDa S-galactosidase band while the recombinant clones consistently showed multiple bands (Fig. 3 ). Of these, only the largest species, corresponding to 135 and 120 kDa, also reacted with affinity purified antibody to apoB (Fig. 3B) .
Thus, the lower molecular weight species presumably represent degraded fusion protein fragments which have lost their apoB portions through proteolysis, a common observation with fusion proteins produced in E. coli. Figure 4 . Expression of apoB mRNA in Hep G2 cells, monkey liver and intestine, and rat liver. Poly(A ) UNA (10 pg/lane) was denatured and electrophoreeed through 0.75% agarose formaldehyde gels, blotted onto nitrocellulose, hybridized with a P-labeled cDNA insert from clone A7h -and autoradiographed overnight at -70°C with an intensifying screen. One lane containing rat liver m (shown at the right) was washed under conditions of reduced stringency (0.5 x SSC at 48°C) to increase the strength of the signal. Previously identified rat apoB cDNA clones hybridize to a mBNA species of identical size (about 20 kb) present in rat liver (data not shown). Comparable results were obtained when cENA isolated from apoB clones A6c, KP2 and A18 were hybridized to PNA from monkey liver. The positions of the major 20 kb apoB band, 18S and 28S riboscmal BNA, and Hind III digested lambda DNA size markers are indicated.
18S
for apoB appears to be present as a single copy in the genome. For example, when human DNA was cut with Hind-III, RP2 cDNA hybridized to a single band 2.8 kb in size (data not shown).
Expression of apoB mRNA.
The four cDNA clones characterized above were used as probes to examine the size, abundance and tissue distribution of mINA for apoB. On
Northern blots of Hep G2 or primate liver HJA all clones hybridized to a single major mPNA species corresponding to about 20 kb (Fig. 4) . Diffuse hybridization in lover molecular weight regions was observed, but since this varied between mBNA preparations, it probably represents partial degradation of this very large mRNA species. Clone A7h also crosshybridized with a mKNA species of identical size present in rat liver (Fig. 4) . Assuming that apoBlOO has a molecular weight of about 400 kDa, which would correspond to a coding region of about 11 kb, this mENA is nearly twice the size necessary to encode human apoBlOO.
All four cDNA clones also hybridized to a mRNA species of about 20 kb present in monkey intestine (Fig. 4) . Densitometric scanning of mFNA preparations showing minimal degradation (Fig. 4) In addition to the major 20 kb band, some preparations of hepatic and intestinal mRNA contained discreet lower molecular weight hybridizing bands.
Most striking was a band approximately 9 kb in size that was present in two separate preparations of monkey intestinal PNA and one preparation of human intestinal PNA (Fig. 4) . Since the primary apoB form secreted by intestine, apoB48, has a molecular weight of about 210 kDa, corresponding to a coding region of about 6 kb, this smaller 9 kb PNA could conceivably encode apoB48.
The relative amounts of the lower molecular weight species, however, varied widely between different ENA preparations; for example, the ratio of the 20 kb signal to the 9 kb signal was approximately 4:1 in one preparation of monkey intestinal RNA (Fig. 4B ) whereas the 9 kb species predominated in a separate preparation (data not shown). Thus, we suspect that the lower molecular weight RNA species represent degradation products of the 20 kb species rather than, for example, products resulting from alternative splicing. The apoB mRNA appears to be extremely susceptible to degradation, as all of our RNA preparations exhibited some hybridization in lower molecular weight regions. This probably results from the extremely large size of the mRNA, since filter hybridization of the same RNA preparations with probes for smaller mRNA species, such as apoA-I and apoE, failed to reveal significant degradation (data not shown).
No specific hybridization to the apoB probes was observed with PNA isolated from monkey tissues which do not secrete apoB, including spleen, muscle, kidney and adrenal gland (data not shown).
On Northern blots containing monkey liver mPNA, hybridization with human apoB probe A7h yielded a signal about 25% as Intense as that observed after hybridization with a human apoE cENA probe of similar size and specific radioactivity (data not shown). Since apoE constitutes roughly 0.1% of the mBNA in primate liver, these results Indicate that apoB is a very abundant mFNA species in liver and intestine.
DISCUSSION
Several cDNA clones for human apoB have been isolated by antibody screening of human hepatoma cDNA libraries in the expression vector Xgtll.
In order to unambiguously establish the identity of the clones, we utilized an antibody specific for a short region of the 400 kDa protein for which sequence information was available. Sequencing of the cDNA thus identified showed that it encoded a 24 amino acid sequence identical in all but three amino acids with that previously derived for a proteolytic fragment of apoB (10) . Other, nonoverlapping cDNA clones were isolated by screening the libraries with antibody to intact apoB. Their identity was established by inmunological characterization of the resulting fusion proteins and by the fact that they hybridize to the same uncommonly large mRNA species ;as the clones containing the known apoB sequence. Moreover, the size of primate mI*JA identified with these probes was identical to that which we previously observed for rat liver apoB mFNA. The cDNA clones were partially characterized and used as probes to examine apoB expression at the level of mRNA. The tissue distribution of apoB mRNA, with abundant expression in liver and intestine but no detectable mKNA in other tissues examined, is consistent with that expected on the basis of protein production and secretion. However, the very large size of the mBNA and the presence of mRNA species of identical size in liver and intestine, raise important questions concerning the biogenesis of apoB.
Eight major apolipoproteins are associated with the various circulating lipoproteins in mammals. Seven of these apolipoproteins (A-I, A-II, A-IV, C-I, C-II, C-III and E) have previously been cloned and sequenced,and they appear to be members of a dispersed gene family derived from a common ancestral sequence. These apolipoproteins consist largely of amphipathic "-helices which are thought to be involved in lipid binding, and they are internally repetitive in terms of both amino acid and nucleic acid sequences (1, (41) (42) (43) (44) . In contrast to these seven previously characterized apolipoproteins, the limited sequence information we have thus far derived for rat (23) and human apoB does not show extensive homology with other apolipopro-teins, nor does the corresponding amino acid sequence exhibit a preponderance of amphipathic oc-helical structure. We have used the apoB probes to map the apoB gene to the pter-q323 region of human chromosome 2 (45); thus, the gene for apoB is unlinked to the gene clusters on chromosomes 1, 11 and 19 that encode the other apolipoproteins. No other significant homologies at the amino acid or nucleic acid level were observed with other proteins or genes.
However, since the sequenced region represents only a few percent of the apoB coding region, questions of internal and external homologies will remain until larger regions of the sequence are determined. Clearly, this will be a large undertaking, but it should now be feasible by techniques such as primer extension from the presently derived clones.
Due to the intractability of the apoB peptides, their molecular properties remain an enigma. He have estimated the sizes of apoBlOO and apoB48 as 400 and 210 kDa, respectively, on the basis of their hydrodynamic properties in guanidine hydrochloride (9) , but other estimates for apoBlOO range from about 250 kDa to 550 kDa (3). Also, a variety of groups have reported lower molecular weight peptides associated with apoB and have suggested that the high molecular weight forms represent aggregates of these (46) (47) (48) (49) (50) (51) (52) . Our present finding of a 20 kb mJNJV, more than sufficient to encode a protein of 400 kDa, is compatible with synthesis of full-length Although these results do not definitively rule out the possibility of a small apoB translation product, we suspect that the smaller peptides observed may represent proteolytic products, since apoB is known to be very susceptible to proteases (54) .
Our finding of a major apoB mRNA species of about 20 kb in both liver and intestine was unexpected since the liver incorporates into VLDL a peptide of about 400 kDa (apoBlOO) while intestine incorporates into chylomicrons a peptide of about 210 kDa (apoB48) (3, (7) (8) (9) (55) (56) (57) (58) . Further studies will be required to determine the explanation for this observation. One possibility is that the liver and intestinal mFNA species, although not discernibly different in size, are not identical as a result of alternative splicing and give rise to separate translation products. Such alternative splicing involving internal exons has been observed in other systems (59) (60) (61) .
Our finding that apoB cDNA clone RP2 hybridizes to a single restriction fragment in Hind III digests of genomic DNA, yet reacts with both liver and intestinal mHNA, strongly supports the concept of a single apoB structural gene which encodes both apoBlOO and apoB48.
Since apoB is required for the assembly and secretion of VLDL and chylomicrons as well as serving as a recognition marker for cellular uptake of LDL (3) (4) (5) , structural and regulatory variations of apoB could alter the structure and metabolism of these lipoproteins. Indeed, studies of patients with familial combined hyperlipldemia and familial hypertriglyceridemia have revealed altered production and catabolism of apoB (15) (16) (17) (18) . Also Rapasz and coworkers have carried out alloantigenic studies of apoB in swine which suggest strongly that certain structural alleles of apoB are associated with hyperlipidemias and aortic intimal lipidosis (19) . The identification of probes for apoB now makes feasible the identification of restriction fragment length polymorphisms as well as apoB alleles to answer questions concerning the role of apoB in hyperlipidemias and atherosclerosis.
